Current treatment options for gastroenteropancreatic neuroendocrine tumors with a focus on the role of lanreotide
Gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are a large and very diverse group of neoplasms. Clinical presentation of NETs depends on the site of the primary tumor and whether the tumor is functioning (i.e., secreting peptides or neuroamines that produce symptoms). The diagnosis of GEP-N...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Termedia Publishing House
2017-06-01
|
| Series: | Contemporary Oncology |
| Subjects: | |
| Online Access: | https://www.termedia.pl/Current-treatment-options-for-gastroenteropancreatic-neuroendocrine-tumors-with-a-focus-on-the-role-of-lanreotide,3,30171,1,1.html |